Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 3.3B | 3.1B | 3.1B |
Cost of revenue | 852.9M | 814.3M | 721.7M | 730.8M |
Gross profit | 2.4B | 2.5B | 2.4B | 2.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 171.5M | 164.8M | 161.5M | 173.7M |
Other operating expenses | 108.8M | 153.2M | 168.1M | 152.5M |
Operating income | 1.1B | 915.6M | 1.0B | 995.3M |
Non operating interest income | ||||
Income | 2.9M | 3.3M | 3.6M | 2.6M |
Expense | 144.0M | 156.0M | 155.4M | 146.0M |
Other income expense | — | — | — | — |
Pretax income | 553.1M | 181.0M | 606.6M | 520.3M |
Tax provision | 164.9M | 19.8M | 166.1M | 104.4M |
Net income | 388.1M | 161.3M | 440.5M | 415.8M |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Basic average shares | 11.7B | 11.7B | 11.7B | 11.7B |
Diluted average shares | 11.7B | 11.7B | 11.7B | 11.7B |
EBITDA | 1.4B | 1.6B | 1.5B | 1.4B |
Net income from continuing op. | 553.1M | 182.3M | 606.6M | 520.3M |
Minority interests | -4.3M | -4.2M | -3.5M | -9.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |